Literature DB >> 84948

Activity of aryl hydrocarbon hydroxylase in psoriatic skin.

P H Chapman, M D Rawlins, S Shuster.   

Abstract

The activity of aryl hydrocarbon hydroxylase (A.H.H.), a microsomal mono-oxygenase, was reduced in epidermis from both the psoriatic lesions and clinically normal lesion-free skin from psoriatic patients. Induction of epidermal A.H.H. activity by benzanthracene was also significantly less than normal in both psoriatic lesions and in clinically normal skin from patients with psoriasis. The enzyme defect may be related to the primary genetic abnormality of the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84948     DOI: 10.1016/s0140-6736(79)90706-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Psoriasis.

Authors:  W F Tucker; S MacNeil
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

2.  Antipyrine clearance and metabolism in patients with psoriasis.

Authors:  K Kubota; T Ishizaki; K Chiba; A Takagi; A Nakagawa; K Nakamura
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  Psoriasis and cancer.

Authors:  P E Polani
Journal:  Br Med J       Date:  1979-05-05

4.  Coal tar therapy. Is it carcinogenic?

Authors:  F J van Schooten; R Godschalk
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

5.  Blood monocyte aryl hydrocarbon hydroxylase activity in psoriasis.

Authors:  G Mason; M D Rawlins; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

6.  A new animal model for the study of cutaneous drug-metabolizing enzymes.

Authors:  G Goerz; H Berger; D Tsambaos
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

7.  Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis.

Authors:  P H Chapman; M D Rawlins; S Shuster; J R Idle; J C Ritchie; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Antipyrine clearance in psoriasis.

Authors:  P H Chapman; B Keys; M D Rawlins; C Moss; S Shuster
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-03

9.  Alterations in leukocyte aryl hydrocarbon hydroxylase activity associated with treatment and age in psoriasis patients and healthy individuals.

Authors:  K H Kraemer; R C Robinson; R E Tarone; M Protic-Sabljic; H V Gelboin
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

10.  Percutaneous absorption and metabolism of lonapalene in psoriatic skin.

Authors:  P A Lehman; R V Tomlinson; J I Johnson; J E Olerud; W A Akers; T J Franz
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.